Navigation Links
SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Date:5/13/2008

said Paul LaViolette, Chief Operating Officer of Boston Scientific. "With the anticipated FDA approval of the XIENCE V (PROMUS) Stent and the launch of the TAXUS Liberte Stent this year, we are excited to offer physicians and their patients two drugs on two highly deliverable platforms."

The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific. The PROMUS and TAXUS Liberte(R) Stents have received CE Mark approval and are distributed in most European countries and other international markets. The XIENCE V (PROMUS) Stent is an investigational device in the U.S. and not yet approved for sale. It is currently under FDA review with an anticipated U.S. launch in 2008.

SPIRIT III is sponsored by Abbott. TAXUS, TAXUS Express2, Express, Liberte and PROMUS are trademarks of Boston Scientific Corporation or its affiliates. XIENCE is a trademark of Abbott Laboratories Group of Companies.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, product performance and competitive offering
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. SPIRIT II Explores Long-Term Performance of XIENCE V Stent
2. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
3. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
4. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
5. Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
6. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
7. DATATRAK International Reports First Quarter Results for 2008
8. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
9. Exelixis Announces First Quarter 2008 Financial Results
10. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
11. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, ... Global Biotechnology, Inc. for the compounding, packaging and distributing of ... in the United States . ... capable of compounding naltrexone tablets in various strengths for individual ...
(Date:1/23/2015)...  HyGreen, Inc., a leader in hand hygiene monitoring, today ... a subsidiary of Ascendis Health Limited, in ... hundreds of millions of patients around the world are ... from patient to patient via the unwashed hands of ...
(Date:1/23/2015)... 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the ... Lixte,s lead compound, LB‑100, is being conducted, has been expanded ... Kovach , M.D., the founder and President of Lixte, said ... a single site. Accrual of patients, however, was slower than ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... , INDIANAPOLIS, Oct. 21 , Higher volume drives revenue growth ... increase to $.86 (reported) or $1.20 (pro forma non-GAAP) Full-year 2009 EPS ... , Eli Lilly and Company (NYSE: LLY ) today announced financial ... per share data Third Quarter, ...
... Massachusetts, October 21 Shire plc,(LSE: SHP, NASDAQ: ... file a Biologics License Application (BLA) with the U.S.,Food ... replacement therapy for Fabry disease, by the end of ... for REPLAGAL, filed at the,request of FDA, has been ...
Cached Medicine Technology:Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 2Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 3Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 4Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 5Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 6Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 7Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 8Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 9Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 10Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 11Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 12Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 13Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 14Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 15Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 16Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 17Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 18Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 19Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 20Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 21Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 4
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently released ... website of AngelWeddingDress.com to find more details. , ... for a bridal party. AngelWeddingDress offers a variety of ... maternity wedding dresses are specially designed for 2015. , ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... Palm City, Florida (PRWEB) January 22, 2015 ... use cold therapy machine with patented IsoTube design to treat ... has introduced the most progressive and easy to use ... help treat post-operative and sports related orthopedic and muscle injuries. ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... have been able to bring an improvement in the ... pulmonary disease (COPD) by teaching them to play the ... of a pulmonary rehabilitation class at the university. The ... chronic obstructive pulmonary disease can focus on their breathing ...
... from osteoporosis from loss of bone mass, there may be ... that it can help improve bone mass in women who ... the principal recommendations for preventing and treating the loss of ... always possible, particularly for the frail., ,An experimental device ...
... of Archives of Internal Medicine said that doctors might ... bio-terrorism that may be caused by smallpox, anthrax, botulism ... tested were unable to correctly diagnose diseases caused by ... test scores improved dramatically for the same physicians after ...
... you are a smoker, says a new study. ... Forest University School of Medicine// examined the relationship between ... study, reports science portal EurekAlert. ,They compared the ... among those who had never smoked. ,Twenty-five percent ...
... the excess weight that one has to carry like excess ... best way is that adopted earlier that is the basic ... Obesity is a big problem these days. , ,Calorie ... of approach towards weight control. ,With so many dietary ...
... walnut sized gland present below the urinary bladder in males. ... that add volume to the semen//. Prostate cancer is the ... of cancer death in American men. The incidence of the ... to cancer prevention, an assessment of the risk factors is ...
Cached Medicine News:
... license agreement between Brook Brothers and ... Characterized by lightweight materials and a ... reflect the unique features of the ... product with classic style and affordable ...
... The new Eyewear collection is a ... and sophisticated in the House of Salvatore ... four mens, as well as up-dates of ... Florentine brand reassert themselves in a brilliant ...
... Vision eyewear includes three collections - Nike ... Ophthalmics, offering active lifestyle consumers the latest ... performance. The sun collections feature Nikes Max ... in a larger vision sweet spot for ...
... technology has redefined rimless collections forever.,The Airlock ... the end of each frame mounting. This ... bushing that mounts within the lens. When ... fit is created that far exceeds that ...
Medicine Products: